Development and validation of prediction scores for nosocomial infections, reoperations, and adverse events in the daily clinical setting of neurosurgical patients with cerebral and spinal tumors
Sebastian Lohmann, Stephanie Schipmann(University of Bergen), Julian Varghese(Otto-von-Guericke-Universität Magdeburg), Nils Warneke, Tobias Brix(University of Münster), Michael Schwake(University Hospital Münster), Walter Stummer(University of Münster), Markus Holling(University Hospital Münster), Eric Suero Molina
Cited by 20
Related Papers
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k